Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report-Reference-Cited by-同舟云学术

Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report

Published:2024-06 Issue:6 Volume:24 Page:1087-1090
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Kumar Pramod^ORCID,Krishna Pradeep^ORCID,Nidoni Ravindra,Adarsh C.K.,Arun M.G.,Shetty Aashish,Mathangi J.,Sandhya ,Gopasetty Mahesh,Venugopal B.

Publisher

Elsevier BV

Reference15 articles.

1. The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation;Choi;Liver Transpl,2017

2. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update;Reig;J Hepatol,2022

3. Downstaging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis on intention-to-treat outcomes;Di Martino;Cancers (Basel),2022

4. Immune checkpoint inhibitor therapy before liver transplantation-case and literature review;Aby;Transplant Direct,2022

5. Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab;Schnickel;Am J Transplant,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downstaging of advanced hepatocellular carcinoma followed by liver transplantation using immune checkpoint inhibitors: Where do we stand?;World Journal of Gastrointestinal Pharmacology and Therapeutics;2024-09-05

2. Immunotherapy Prior to a Liver Transplant: Literature Review and a Case Report of Hepatocellular Carcinoma With BRCA1 Mutation;Innovative Medicine of Kuban;2024-08-23

3. Gold Nano Frameworks with Mesopores for Synergistic Immune-Thermal Therapy in Hepatic Carcinoma: A Paradigm Shift in Immune Checkpoint Blockade;ACS Applied Materials & Interfaces;2024-08-22

4. Evolution of Systemic Treatment for Hepatocellular Carcinoma: Changing Treatment Strategies and Concepts;Cancers;2024-06-28

5. Reply to: “Patients with hepatocellular carcinoma and portal vein tumour thrombosis after successful downstaging may be candidates for liver transplantation: A meta-analysis”;Journal of Hepatology;2024-05